108 related articles for article (PubMed ID: 3402255)
1. Human recombinant mullerian inhibiting substance inhibits epidermal growth factor.
Coughlin JP; Cigarroa F; Donahoe PK; McLaughlin DT
Curr Surg; 1988; 45(3):204-5. PubMed ID: 3402255
[No Abstract] [Full Text] [Related]
2. A possible purification of mullerian inhibiting substance and a model for its mechanism of action.
Budzik GP; Donahoe PK; Hutson JM
Prog Clin Biol Res; 1985; 171():207-23. PubMed ID: 2984697
[No Abstract] [Full Text] [Related]
3. Cytotoxic effects of müllerian inhibiting substance (MIS)?
Janssens JP; Noto V; van Tendeloo G; Bonte J; de Loecker W
Anticancer Res; 1988; 8(4):781-4. PubMed ID: 3178166
[TBL] [Abstract][Full Text] [Related]
4. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
5. Mullerian inhibiting substance binding and uptake.
Catlin EA; Ezzell RM; Donahoe PK; Manganaro TF; Ebb RG; MacLaughlin DT
Dev Dyn; 1992 Apr; 193(4):295-9. PubMed ID: 1511169
[TBL] [Abstract][Full Text] [Related]
6. Re: Testicular descent: a proposed interaction between müllerian inhibiting substance and epidermal growth factor.
Barthold JS
J Urol; 1998 Oct; 160(4):1438-40. PubMed ID: 9751382
[No Abstract] [Full Text] [Related]
7. Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase.
Cigarroa FG; Coughlin JP; Donahoe PK; White MF; Uitvlugt N; MacLaughlin DT
Growth Factors; 1989; 1(2):179-91. PubMed ID: 2560399
[TBL] [Abstract][Full Text] [Related]
8. Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.
Chin TW; Parry RL; Donahoe PK
Cancer Res; 1991 Apr; 51(8):2101-6. PubMed ID: 2009529
[TBL] [Abstract][Full Text] [Related]
9. Müllerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase.
Coughlin JP; Donahoe PK; Budzik GP; MacLaughlin DT
Mol Cell Endocrinol; 1987 Jan; 49(1):75-86. PubMed ID: 3030847
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
[TBL] [Abstract][Full Text] [Related]
11. Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.
Wallen JW; Cate RL; Kiefer DM; Riemen MW; Martinez D; Hoffman RM; Donahoe PK; Von Hoff DD; Pepinsky B; Oliff A
Cancer Res; 1989 Apr; 49(8):2005-11. PubMed ID: 2702642
[TBL] [Abstract][Full Text] [Related]
12. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
Fuller AF; Guy S; Budzik GP; Donahoe PK
J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
[TBL] [Abstract][Full Text] [Related]
13. Initiation of production of anti-müllerian hormone by the fetal gonad.
Josso N; Vigier B; Tran D; Picard JY
Arch Anat Microsc Morphol Exp; 1985; 74(1):96-100. PubMed ID: 3840970
[No Abstract] [Full Text] [Related]
14. Mullerian inhibiting substance in the ovary.
Donahoe PK; Takahashi M; Ueno S; Manganaro TF
Prog Clin Biol Res; 1988; 267():153-75. PubMed ID: 3070561
[No Abstract] [Full Text] [Related]
15. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
Weniger JP; Zeis A
Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
[TBL] [Abstract][Full Text] [Related]
16. Müllerian inhibiting substance.
Bashir MS; Wells M
J Pathol; 1995 Jun; 176(2):109-10. PubMed ID: 7636619
[No Abstract] [Full Text] [Related]
17. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
18. Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive.
Maggard MA; Catlin EA; Hudson PL; Donahoe PK; MacLaughlin DT
Metabolism; 1996 Feb; 45(2):190-5. PubMed ID: 8596488
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of müllerian inhibiting substance in preterm and term male neonates.
Schwindt B; Doyle LW; Hutson JM
J Urol; 1997 Aug; 158(2):610-2. PubMed ID: 9224378
[TBL] [Abstract][Full Text] [Related]
20. Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
Elder JS
J Urol; 1997 Oct; 158(4):1637. PubMed ID: 9302191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
